Treatment of corneal ulcers in ocular surface inflammation

Purpose severe ocular surface inflammation can be lead to different diseases and can cause severe corneal involvement Methods 5 cases of ocular surface inflammation with severe corneal ulcers resistant to conventional treatment , all treated with à new matrix therapy agent (cacicol 20%) 1 drop a day...

Full description

Saved in:
Bibliographic Details
Published in:Acta ophthalmologica (Oxford, England) England), 2014-09, Vol.92 (s253), p.0-0
Main Author: LAZREG, S
Format: Article
Language:English
Subjects:
Ophthalmology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose severe ocular surface inflammation can be lead to different diseases and can cause severe corneal involvement Methods 5 cases of ocular surface inflammation with severe corneal ulcers resistant to conventional treatment , all treated with à new matrix therapy agent (cacicol 20%) 1 drop a day every other day for 4 weeks , with biomicroscopic records at D0 , D3, D7, D 15 and D30. Results patients were aged between 18 to 66 years old, ocular surface inflammation was due to GVHD, severe Sjögren's Syndrome, Atopic keratoconjuctivitis, ocular pymphygoide and Stevens Johnson syndrome, all ulcers were chronic and rebels to different treatment ,at D7 we observed a decrease on VAs pain scale at D15 in all cases a total epitheliazitation of the ulcers , Conclusion CACICOL 20® is a new ophthalmic device, derived from RGTA based matrix therapy (large biopolymers engineered to replace heparan sulfates) , wich is a revolution in treatment of chronic ulcers, in our cases it has a double effect antalgic and regenerating;
ISSN:1755-375X
1755-3768
DOI:10.1111/j.1755-3768.2014.S037.x